Kap Code
Kap Code is a Paris-based digital health startup that uses AI and natural language processing to analyze patient discussions on social networks for pharmacovigilance, real-world evidence, and chronic-disease patient support, serving pharmaceutical companies, healthcare organizations, and public health authorities primarily across Europe.
- Company typePrivate
- Founded2017
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Kap Code does
Kap Code is a Paris-headquartered digital health startup founded in 2017 after spinning out of Kappa Santé, where the team originated in 2009 to explore social networks as sources of real-world health data. The company builds AI- and natural-language-processing solutions that mine health conversations on social networks, forums, and patient communities to extract patient experience indicators, care pathway insights, pharmacovigilance signals, and unmet medical needs. Its flagship product, Detec't, is a medical social-listening platform offered with three commercial angles (medical, marketing, and market access); the portfolio is extended by Connect'inh, a connected inhaler paired with a companion app for asthma monitoring, and W'asm, an edutainment patient-support program featuring a video-analysis module that scores inhaler technique. The company also offers digital-transformation consulting services to healthcare clients.
Kap Code operates a B2B enterprise sales motion targeting pharmaceutical companies, healthcare organizations, and public health authorities, primarily in France with documented activity in the United Kingdom, Germany, Spain, the Netherlands, Italy, and the United States. Revenue is generated through what is described as a subscription/recurring commercial model with quote-based pricing on subscriptions and project work, including pharmacovigilance analytics, real-world evidence studies, and consulting engagements. The company was part of the inaugural Future4care accelerator cohort (backed by Sanofi, Capgemini, Generali, and Orange) and has used co-developed research (notably with Harvard University's Nock Lab and ArcaScience) as a credibility lever. It is privately held as a Société par Actions Simplifiée Unipersonnelle with registered capital of approximately €594,160 and no disclosed external institutional investors beyond an early round attributed to Investisseurs & Partenaires in 2017.
The operating model is light on capital intensity relative to peers: 11–50 employees, a small in-house data-science function, and a heavy reliance on scientific publications (including in JMIR) and event-based thought leadership rather than large-scale performance marketing. Strategic customers and collaborators named in source materials include Sanofi (atopic dermatitis study), Harvard's Nock Lab (suicide-prevention algorithms), Université Paris Saclay (academic partnership and digital-health degree), Yakadir and Better World (patient expression observatory), and patient associations such as #ApresJ20 — Covid Long France.
Kap Code firmographics
Firmographics- Name
- Kap Code
- Legal name
- Kap Code
- Website
- https://kapcode.fr
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kap Code is a Paris-based digital health startup that uses AI and natural language processing to analyze patient discussions on social networks for pharmacovigilance, real-world evidence, and chronic-disease patient support, serving pharmaceutical companies, healthcare organizations, and public health authorities primarily across Europe.
- Ownership category
- akta.pro rank
Kap Code industry classification
Industry- Product category
- Digital Health Analytics & Pharmacovigilance Software
- NAICS
- Software Publishers (513210), Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
- akta.pro secondary industries
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Electronic Data Capture (EDC) Platforms (HLACAOAA)
Keywords
Where Kap Code is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Kap Code business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- B2B Software/Services: Provides software solutions and services to pharmaceutical companies, healthcare organizations, and public health authorities. Revenue generated from analysis of social media data, patient support programs, and digital transformation consulting.
- Pharmacovigilance Analysis: Real-world data analysis services for drug safety monitoring and pharmacovigilance applications, combining social media data with biomedical data for enhanced drug surveillance.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
Kap Code product offering
Product offeringCore offering
Kap Code develops AI and natural language processing software that analyzes patient discussions on social networks and medical forums to extract real-world health insights, including quality-of-life data, care pathway information, unmet medical needs, and pharmacovigilance signals. Its flagship product Detec't is a medical social listening platform sold to pharmaceutical companies, complemented by the W'asm patient education platform and Connect'inh connected inhaler device for asthma patients, plus digital transformation consulting services for healthcare organizations.
Product overview
Kap Code offers a portfolio of digital health solutions centered on patient experience and real-world evidence from social networks. The core product is Detec't, an AI-powered medical social listening platform that analyzes patient discussions on social media and forums to extract health insights. This is complemented by patient support programs including W'asm (an educational platform for asthma patients with video-based inhalation technique analysis) and Connect'inh (a connected device and app for asthma monitoring). The company also provides digital transformation consulting services. The portfolio spans social media analytics, connected health devices, therapeutic education platforms, and strategic consulting, all oriented toward helping pharmaceutical companies, healthcare providers, and patient organizations better understand and serve patient needs.
Differentiator
Problem solved
Functional benefit
Brands
- Detec't: Medical social listening tool using AI and natural language processing to monitor patient experience and extract quality of life, care pathway, and unmet medical needs data from social networks.
- Connect'inh
- W'asm
- Epilogue
Products and services
- Detec't Medical social listening platform using artificial intelligence and natural language processing to monitor patient experience on social networks (Twitter, Facebook, forums, YouTube, Reddit, health communities), extracting quality of life data, care pathway insights, and unmet medical needs for pharmaceutical, healthcare, and public health stakeholders.
- W'asm Personalized patient support program for asthma patients featuring a video analysis module for assessing and improving inhalation technique, combined with edutainment educational modules to improve disease knowledge and treatment adherence.
- Connect'inh Connected inhaler device paired with a mobile application that enables asthma patients to track and manage their respiratory condition in real time, providing data collection for remote monitoring and patient empowerment.
- Transformation digitale Digital transformation consulting service offering personalized support for healthcare companies' digital projects across conception, development, and evaluation phases.
Quantifiable outcome
- 38% of WHO VigiBase pharmacovigilance signals could have been detected earlier using Detec't
- +1 more outcomes
Companies that use Kap Code
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles3 records
Kap Code technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature4 records
Kap Code partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- ArcaSciencecorePartnership announced at Future4care Festival 2022. Combines Kap Code's real-world data analysis from social networks with ArcaScience's biomedical data expertise to develop new pharmacovigilance tools based on AI. Both companies are members of Future4care accelerator's first cohort.
- Nock Lab, Harvard UniversitycoreCollaboration to develop algorithms for identifying suicidal thoughts on social networks. Combines Nock Lab's suicide prevention expertise with Kap Code's machine learning capabilities. Project aims to create tools for early identification of at-risk individuals for intervention.
- Future4carecoreEuropean e-health startup accelerator launched by Sanofi, Capgemini, Generali, and Orange. Kap Code was part of the first cohort of ~20 startups accepted in late 2021. Partnership catalyzed the ArcaScience collaboration.
- Kappa SantécoreCRO (Contract Research Organization) specializing in real-world data. Kap Code originated as an R&D team within Kappa Santé in 2009 before becoming an independent startup in 2017.
- Yakadir and Better WorldminorPartnership to launch observatory of patient expression and experience, combining expertise in patient experience measurement.
- Université Paris SaclayminorAcademic partnership including co-direction of Digital Health university degree by GM Adel Mebarki; participation in e-cohort CONFINS study on student mental health during COVID-19; involvement of Master of Pharmaceutical Marketing students in writing health articles.
- Healthcare Data InstituteminorParticipated in Healthcare Data Institute working group on social media and health in 2018, contributing to white paper on the topic.
- Centre de recherche des CordeliersminorResearch partnership with this academic research center focused on interdisciplinary health research.
- Bordeaux Population HealthminorAcademic partnership with Bordeaux Population Health research group for population health studies.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Kap Code competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the global leader in real-world evidence and pharma analytics, with social and patient-experience data capabilities as part of a much broader portfolio — competes with Kap Code for pharma RWE budgets.
Emerging players
- Owkin: Owkin is a French AI-for-health company applying machine learning to biomedical and clinical data for pharma — a regional emerging player comparable in geography and customer base.
- ArcaScience: ArcaScience is an AI-driven patient-centric benefit-risk and pharmacovigilance platform that partners with Kap Code; it overlaps on pharma real-world data and drug safety analytics.
- Nabla: Nabla is a French digital health AI company focused on clinician and patient experiences; comparable as a fellow Paris-based AI-health startup targeting pharma/providers.
Direct peers
- Sermo: Sermo is a physician social network that also generates HCP insights and real-world data for pharma, sharing Kap Code's model of mining online healthcare conversations for actionable intelligence.
- Creation Healthcare: Creation Healthcare is a medical social listening and HCP/patient insight company that analyses online healthcare conversations for pharma — a direct competitor to Kap Code's Detec't offering.
- ListenLogic: ListenLogic delivers social listening and analytics for healthcare and life sciences, including patient experience and brand insights — closely comparable to Detec't's pharma use cases.
- ConversationHealth: ConversationHealth applies AI/NLP to patient and HCP conversations for pharma insights and engagement, overlapping directly with Kap Code's medical social listening and patient engagement focus.
Others
- Cision: Cision is a PR and earned-media analytics platform with social listening capabilities, adjacent to Kap Code's data collection layer for pharmaceutical communications and patient insights.
- Brandwatch: Brandwatch is a general-purpose consumer social listening platform that Kap Code uses as a data supplier; it's an enabling/adjacent peer rather than a direct competitor in medical social listening.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Kap Code social profiles
Digital presenceKap Code financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kap Code leadership team
Management profileNumber of profiles
Profiles9 records
Kap Code funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kap Code M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kap Code
What does Kap Code do?
Kap Code develops AI and natural language processing software that analyzes patient discussions on social networks and medical forums to extract real-world health insights, including quality-of-life data, care pathway information, unmet medical needs, and pharmacovigilance signals. Its flagship product Detec't is a medical social listening platform sold to pharmaceutical companies, complemented by the W'asm patient education platform and Connect'inh connected inhaler device for asthma patients, plus digital transformation consulting services for healthcare organizations.
Is Kap Code a public or private company?
Kap Code is a private company. It is classified as venture growth investor backed and is currently operating.
When was Kap Code founded?
Kap Code was founded in 2017. It employs 11 to 50 people.
Where is Kap Code based?
Kap Code is headquartered in Paris, France, in the Europe region.
How does Kap Code make money?
Two revenue lines are on record. B2B Software/Services are the primary driver. The others are pharmacovigilance Analysis.
Who are Kap Code's main competitors?
IQVIA is listed as a broad incumbent. Emerging players are Owkin, ArcaScience and Nabla. Direct peers are Sermo, Creation Healthcare, ListenLogic and ConversationHealth. Others are Cision and Brandwatch.
Does Kap Code have an API?
No public API is recorded for Kap Code.
What industry is Kap Code in?
Kap Code's product category is Digital Health Analytics & Pharmacovigilance Software. Its primary akta.pro industry code is HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 513210 and its SIC code is 7372.